Publications of Martin A. Kohli
All genres
Journal Article (22)
2019
Journal Article
95, 109686 (2019)
Polymorphisms in the BDNF and BDNFOS genes are associated with hypothalamus-pituitary axis regulation in major depression. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 2015
Journal Article
: Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. NATURE NEUROSCIENCE 18 (2), pp. 199 - 209 (2015)
2012
Journal Article
: Polymorphisms within the metabotropic glutamate receptor 1 gene are associated with depression phenotypes. Psychoneuroendocrinology 37 (4), pp. 565 - 575 (2012)
2011
Journal Article
: Gene-PUFA interactions and obesity risk. British Journal of Nutrition 106 (8), pp. 1263 - 1272 (2011)
Journal Article
: BDNF and NTRK2 polymorphisms and antidepressant treatment outcome. Pharmacopsychiatry 44 (6), p. 295 - 295 (2011)
Journal Article
: TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Molecular Psychiatry 16 (6), pp. 647 - 663 (2011)
Journal Article
: BDNF and NTRK2 Polymorphisms and Antidepressant Treatment Response. Biological Psychiatry 69 (9 Suppl.1), p. 152 S - 152 S (2011)
2010
Journal Article
: Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression. Molecular Psychiatry 15 (7), pp. 736 - 747 (2010)
Journal Article
: Polymorphisms in the BDNF Gene are Associated with Antidepressant Treatment Response. Biological Psychiatry 67 (9 Suppl.1), pp. 127S - 128S (2010)
Journal Article
: Association of Genetic Variants in the Neurotrophic Receptor-Encoding Gene NTRK2 and a Lifetime History of Suicide Attempts in Depressed Patients. Archives of General Psychiatry 67 (4), pp. 348 - 359 (2010)
2009
Journal Article
: Pharmacogenetics of antidepressant treatment outcome - Results from a genome-wide multilocus analysis including clinical predictors. Annals of Human Genetics 73, pp. 665 - 666 (2009)
Journal Article
: A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression. Archives of General Psychiatry 66 (9), pp. 966 - 975 (2009)
Journal Article
: A genome-wide association study points to multiple loci predicting antidepressant treatment outcome in depression. Pharmacopsychiatry 42 (5), p. 224 - 224 (2009)
Journal Article
: Polymorphisms in tryptophan hydroxylase 2 leading to decreased serotonergic activity contribute to elevated risk for metabolic syndrome in depression. Pharmacopsychiatry 42 (5), p. 226 - 226 (2009)
Journal Article
: The neuronal transporter gene SLC6A15 confers risk to major depression. Pharmacopsychiatry 42 (5), p. 230 - 230 (2009)
2008
Journal Article
18 (Suppl. 4), p. S296 - S296 (2008)
Variations in tryptophan hydroxylase 2 are associated with elevated risk for metabolic syndrome in depression. European Neuropsychopharmacology
Journal Article
: Polymorphisms in the drug transporter Gene ABCB1 predict antidepressant treatment response in depression. Neuron 57, pp. 203 - 209 (2008)
Journal Article
: Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder. Journal of Affective Disorders 105, pp. 177 - 184 (2008)
2007
Journal Article
: SNPs in the NTRK2 gene are associated with depressive disorder. Pharmacopsychiatry 40 (5), p. 212 - 212 (2007)
Journal Article
: Susceptibility gene hunting for recurrent unipolar depression using 400k genome-wide genotype data. Pharmacopsychiatry 40 (5), p. 212 - 212 (2007)